Dr. Riley Kirk fuses approachable cannabis science with community-driven education, driving a cultural shift and dismantling marijuana stigma through her research and social media influence.

An evidence-based examination of THC delivery methods, CBD dosing protocols, therapeutic mechanisms, and legal frameworks across DC and Virginia.

A landmark investigation reveals Oregon’s licensed psilocybin service centers are exceeding safety and compliance standards, but economic barriers limit broader access.

An in-depth look at Ascend Cannabis in downtown Cincinnati, product delivery methods, scientific pharmacokinetics, and lessons for DMV consumers.

New policy research reveals that interactive regulatory QR codes significantly boost consumer trust, safety awareness, and legal market participation.

Federal health officials and clinical experts met in Silver Spring to establish safety, credentialing, and access standards for psychedelic medicines.

Explore how employer-sponsored medical cannabis benefits are cutting healthcare costs, backed by clinical research and DMV access updates.

A new study reveals that cannabigerol (CBG) preserved long-term memory in animal models using an unexpected molecular pathway.

Johnson & Johnson leads an $85 million Series C round for Delix Therapeutics, signaling growing corporate interest in novel therapies.

New research from 2025 looked at how heavy cannabis use impacts cognitive function. This article unpacks the findings and provides context for DMV cannabis consumers.